A carregar...
Acute Myocardial Infarction after Switching from Warfarin to Dabigatran
Dabigatran etexilate is a recently approved direct thrombin inhibitor (DTI), which is superior to warfarin in the prevention of stroke and systemic embolism in patients with atrial fibrillation (AF). However, dabigatran use is associated with an increased risk of myocardial infarction (MI) compared...
Na minha lista:
Publicado no: | Oman Med J |
---|---|
Main Authors: | , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
OMJ
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4371461/ https://ncbi.nlm.nih.gov/pubmed/25830002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5001/omj.2015.10 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|